Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-06-16

Clinical Trial Update: Medical Versus Surgical Management of Moderate Mitral Regurgitation Following Percutaneous Coronary Intervention [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating medical versus surgical management of moderate mitral regurgitation after percutaneous coronary intervention has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Southern Illinois University | Conditions: Myocardial Infarction, Mitral Regurgitation | Phase 1, Phase 2 | Status: WITHDRAWN